Aclaris Therapeutics, Inc. Quarterly Share-based Payment Arrangement, Expense in USD from Q3 2014 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Aclaris Therapeutics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q3 2014 to Q3 2024.
  • Aclaris Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $3M, a 49.5% decline year-over-year.
  • Aclaris Therapeutics, Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $9.26M, a 61.6% decline year-over-year.
  • Aclaris Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $20.5M, a 36.6% increase from 2022.
  • Aclaris Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $15M, a 6.96% increase from 2021.
  • Aclaris Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $14.1M, a 25.5% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $9.26M $3M -$2.94M -49.5% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-06
Q2 2024 $12.2M $2.9M -$3.62M -55.5% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-07
Q1 2024 $15.8M $2.09M -$4.72M -69.3% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-07
Q4 2023 $20.5M $1.27M -$3.55M -73.7% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-27
Q3 2023 $24.1M $5.95M +$1.76M +42% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-06
Q2 2023 $22.3M $6.52M +$2.83M +76.7% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-07
Q1 2023 $19.5M $6.81M +$4.46M +190% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q4 2022 $15M $4.81M +$2.12M +78.7% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-27
Q3 2022 $12.9M $4.19M +$486K +13.1% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-06
Q2 2022 $12.4M $3.69M -$140K -3.65% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-07
Q1 2022 $12.6M $2.35M -$1.49M -38.8% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-08
Q4 2021 $14.1M $2.69M +$190K +7.59% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-27
Q3 2021 $13.9M $3.7M +$1.76M +90.7% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 $12.1M $3.83M +$523K +15.8% Apr 1, 2021 Jun 30, 2021 10-Q 2021-08-05
Q1 2021 $11.6M $3.83M +$379K +11% Jan 1, 2021 Mar 31, 2021 10-Q 2022-08-03
Q4 2020 $11.2M $2.5M -$684K -21.5% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-23
Q3 2020 $11.9M $1.94M -$2.08M -51.8% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-02
Q2 2020 $14M $3.31M -$1.29M -28% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 $15.3M $3.45M -$819K -19.2% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-07
Q4 2019 $16.1M $3.19M +$964K +43.3% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-24
Q3 2019 $15.1M $4.02M +$77K +1.95% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-04
Q2 2019 $15M $4.6M -$651K -12.4% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-07
Q1 2019 $15.7M $4.27M -$871K -16.9% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q4 2018 $16.6M $2.22M -$225K -9.19% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-25
Q3 2018 $16.8M $3.95M +$274K +7.46% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-07
Q2 2018 $16.5M $5.25M +$1.95M +58.9% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-08
Q1 2018 $14.6M $5.14M +$1.99M +63.1% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-08
Q4 2017 $12.6M $2.45M +$539K +28.2% Oct 1, 2017 Dec 31, 2017 10-K 2020-02-25
Q3 2017 $12M $3.67M +$2.06M +127% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-06
Q2 2017 $9.99M $3.3M +$1.95M +144% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-03
Q1 2017 $8.04M $3.15M +$1.93M +158% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-08
Q4 2016 $6.1M $1.91M +$1.26M +195% Oct 1, 2016 Dec 31, 2016 10-K 2019-03-18
Q3 2016 $4.84M $1.62M +$1.46M +924% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-07
Q2 2016 $3.38M $1.35M +$1.31M +3124% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-08
Q1 2016 $2.07M $1.22M +$1.18M +2742% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-09
Q4 2015 $891K $648K Oct 1, 2015 Dec 31, 2015 10-K 2018-03-12
Q3 2015 $158K +$152K Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-03
Q2 2015 $42K Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-11
Q1 2015 $43K Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-11
Q3 2014 $6K* Jul 1, 2014 Sep 30, 2014 10-Q/A 2015-12-03
* An asterisk sign (*) next to the value indicates that the value is likely invalid.